DR Reddys Laboratories Limited Glimepiride Export Data — India (DGFT 2022–2026)

Name: DR Reddys Laboratories Limited Glimepiride Export Records India — #12 Exporter, 6 Shipments, $300.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Glimepiride

India Pharmaceutical Trade Intelligence

$76.3M242 Suppliers94 CountriesHS 30049099

ExportsIndia → UNITED STATES67.1%India → SOUTH AFRICA4.8%

ImportsMALTA → India$43.6K GREECE → India$5.3K

#1 Supplier: INDOCO REMEDIES #1 Buyer: EVERSANA LIFE

DR Reddys Laboratories Limited — Glimepiride Exporter #12 | $300.0K Trade Value | TransData Nexus | TransData Nexus

DR Reddys Laboratories Limited — Glimepiride Exporter Profile

Indian Pharmaceutical Exporter · #12 for Glimepiride · $300.0K export value · DGFT Verified

DR Reddys Laboratories Limited is the #12 Indian exporter of Glimepiride with $300.0K in export value and 6 verified shipments. DR Reddys Laboratories Limited holds a 0.4% market share in Glimepiride exports across 1 countries. The company exports 37 pharmaceutical products worth $62.4M across 17 therapeutic categories.

DR Reddys Laboratories Limited — Glimepiride Export Profile: Buyers & Destinations

DR Reddys Laboratories Limited Glimepiride export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Glimepiride?

Country	Value	Shipments	Share
UNITED STATES	$8.7M	174	32.8%
SOUTH AFRICA	$3.7M	96	13.8%
PHILIPPINES	$3.4M	157	12.8%
JAPAN	$2.1M	42

Who Are the Top Buyers of Glimepiride from India?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES, LLC	UNITED STATES	$1.3M	51
EVERSANA LIFE SCIENCE SERVICES LLC	UNITED STATES	$905.2K	25
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$780.5K	109
MEIJI SEIKA PHARMATECH CO LIMITED	JAPAN	$750.0K	15
AMERISOURCE HEALTH SERVICES	UNITED STATES	$704.6K	38
MEIJI SEIKA PHARMATECH CO., LTD	JAPAN	$650.0K	13
AJANTA PHARMA PHILIPPINES INC	PHILIPPINES	$600.0K	12
I.E. MEDICA INC.	PHILIPPINES	$574.6K	15
DR REDDYS LABORATORIES INC	UNITED STATES	$300.0K	6
XX REXXYS XXBORXXORIXX INXX	UNITED STATES	$100.0K	2

India's Glimepiride is purchased by 535 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES), followed by EVERSANA LIFE SCIENCE SERVICES LLC and APL SWIFT SERVICES (MALTA) LTD.,.

How Does DR Reddys Laboratories Limited Compare to Nearest Glimepiride Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
14	AZTEC PHARMA PRIVATE LIMITED	$607.9K	25	1	$24.3K
15	INTAS PHARMACEUTICALS LIMITED	$508.7K	40	4	$12.7K
12	DR REDDYS LABORATORIES LIMITED ★	$300.0K	6	1	$50.0K
7	FREDUN PHARMACEUTICALS LTD	$200.0K	4	1	$50.0K
11	DR REDDY S LABORATORIES LIMITED	$150.0K	3	1	$50.0K

DR Reddys Laboratories Limited ranks #12 among 242 Indian Glimepiride exporters. Average shipment value of $50.0K compared to the market average of $96.6K. The closest competitors by value are AZTEC PHARMA PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Glimepiride Exports?

Port	Shipments	% Share
SAHAR AIR	350	11.1%
NHAVA SHEVA SEA (INNSA1)	268	8.5%
SAHAR AIR CARGO ACC (INBOM4)	241	7.6%
DELHI AIR CARGO ACC (INDEL4)	228	7.2%
DELHI AIR	226	7.2%
JNPT/ NHAVA SHEVA SEA	172	5.4%
BANGALORE ACC (INBLR4)	148	4.7%
BANGALORE AIR	110	3.5%

Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Glimepiride Exports

The global pharmaceutical export landscape has been significantly influenced by recent geopolitical events. The 2026 Strait of Hormuz crisis, initiated by military conflicts involving the United States, Israel, and Iran, led to the effective halt of shipping traffic through this critical maritime route, disrupting approximately 20% of the world's daily oil supply and causing a surge in global energy prices. (en.wikipedia.org) This disruption has had a cascading effect on shipping costs and insurance premiums, directly impacting Indian pharmaceutical exporters like Dr. Reddy's, which rely on these routes for timely delivery of products to key markets.

Simultaneously, the 2025–26 United States–India diplomatic and trade crisis, marked by the imposition of a 50% tariff on Indian exports by the U.S., has posed additional challenges. These tariffs have increased the cost of Indian pharmaceutical products in the U.S. market, potentially affecting the competitiveness of companies like Dr. Reddy's. (en.wikipedia.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. Dr. Reddy's has been proactive in adhering to these regulations, ensuring that its products meet the stringent safety and traceability standards mandated by the EU, thereby maintaining its market access and reputation.

DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Dr. Reddy's has demonstrated a commitment to quality by securing approvals from major regulatory bodies, including the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Medicines Agency (EMA). The company's recent Biologics License Application (BLA) submission for a proposed interchangeable biosimilar to Orencia® (abatacept) underscores its adherence to rigorous regulatory processes. (stockwatch.com)

However, the company has faced regulatory challenges, such as the tax audit decision from the Russian Federal Tax Service in January 2026, which reclassified certain marketing services as taxable, resulting in a penalty. (stocktitan.net) Such incidents highlight the complexities of operating in diverse regulatory environments and the importance of robust compliance frameworks.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Glimepiride shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: DR Reddys Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 94+ countries, 535+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Glimepiride

Glimepiride

DR Reddys Laboratories Limited — Glimepiride Exporter Profile

DR Reddys Laboratories Limited — Glimepiride Export Profile: Buyers & Destinations

Where Does India Export Glimepiride?

Who Are the Top Buyers of Glimepiride from India?

What Is India's Total Glimepiride Export Value and How Much Does DR Reddys Laboratories Limited Contribute?

What Is the Average Shipment Value for DR Reddys Laboratories Limited's Glimepiride Exports?

How Does DR Reddys Laboratories Limited Compare to Other Indian Glimepiride Exporters?

Regulatory Requirements: Exporting Glimepiride to Key Markets

United States — FDA

South Africa — SAHPRA

How Does DR Reddys Laboratories Limited Compare to Nearest Glimepiride Exporters?

Which Indian Ports Ship Glimepiride Exports?

Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Glimepiride Exports

DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards

About DR Reddys Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Glimepiride Export Data from DR Reddys Laboratories Limited

Glimepiride Stats

Company Overview

Top Products by DR Reddys Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source